Jose Visit 3: 51-year-old patient with type 2 diabetes, 2 years after initial visit
| Title: | Jose Visit 3: 51-year-old patient with type 2 diabetes, 2 years after initial visit |
| Topic: | Diabetology |
| Relevant Terms: | Diabetes, Diabetes Complications, Dyslipidemia, Endocrinology, Hypertension, Insulin Resistance, Macrovascular Disease, Microvascular Disease, Type 2 Diabetes |
| Primary Audience: | Primary care providers and other healthcare professionals who treat adults with diabetes |
| Launch Date: | 05-Jan-10 |
| Credits: | 0.5 AMA PRA Category 1 Credit™ |
| Expiration Date: | 04-Jan-11 |
Learning Objectives
Upon completion of the activity, participants should be able to:
- Explain the natural history of type 2 diabetes including the evolution of insulin resistance and insulin secretory decline as key factors in the clinical progression of the disease
- Translate the process of selecting and advancing treatment regimens that balance physiologic needs with individualized self-care considerations for type 2 diabetes into the outpatient setting via improved and coordinated systems of care
- Identify the most common medical, personal, social, and cultural factors that influence adherence to diabetes treatment plans
- Recognize the value of motivational interviewing as a potential strategy to improve provider-patient interaction in the clinical setting
- Employ appropriate tests and data collection to assist in the management of people with diabetes who are not achieving their targeted treatment goals
- Integrate a comprehensive treatment plan for people with diabetes that includes nonpharmacologic and pharmacologic interventions that are based on individual medical, social, and cultural factors
- Formulate and implement office-based systems to manage treatment and facilitate therapeutic advancement
Faculty
Kenneth Snow, MD, MBA
Assistant Clinical Professor of Medicine
Harvard Medical School
Senior Physician Advisor, Strategic Initiatives
Joslin Diabetes Center
Boston, MA
Philip Levy, MD, FACE
Clinical Professor of Medicine
University of Arizona College of Medicine
President, Phoenix Endocrinology Clinic
Phoenix, AZ
Arturo R. Rolla, MD
Assistant Clinical Professor of Medicine
Harvard Medical School
Assistant Clinical Professor of Medicine
Tufts University School of Medicine
Endocrinologist, Beth Israel Deaconess Medical Center
Boston, MA
Assistant Clinical Professor of Medicine
Harvard Medical School
Senior Physician Advisor, Strategic Initiatives
Joslin Diabetes Center
Boston, MA
Philip Levy, MD, FACEClinical Professor of Medicine
University of Arizona College of Medicine
President, Phoenix Endocrinology Clinic
Phoenix, AZ
Arturo R. Rolla, MD Assistant Clinical Professor of Medicine
Harvard Medical School
Assistant Clinical Professor of Medicine
Tufts University School of Medicine
Endocrinologist, Beth Israel Deaconess Medical Center
Boston, MA
Planning Committee:
Julie Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA
James Neighbours, MEd
Assistant Director, Education Technology Services
Professional Education
Joslin Diabetes Center
Boston, MA
DISCLOSURE POLICY STATEMENT
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of the Joslin Diabetes Center.
Dr. Snow has no relevant financial relationships.
Dr. Levy has received grant/research support from, is on the speakers bureau and a consultant for Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Pfizer Inc. He is on the speaker's bureau and a consultant for Bristol-Myers Squibb Company, Daiichi Sankyo Inc., GlaxoSmithKline, Merck & Co. Inc., and Takeda Pharmaceuticals North America, Inc. He is a consultant for Boehringer Ingelheim Pharmaceuticals, Inc. Dr. Levy has received grant/research support from Novartis Pharmaceuticals Corporation and Novo Nordisk Inc.
Dr. Rolla is on the speakers bureau for Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk Inc., and F. Hoffman-La Roche Ltd.
Dr. Beaser is on the academic advisory board for AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company.
Ms. Brown has no relevant financial relationships.
Mr. Neighbours has no relevant financial relationships.
ACCREDITATION STATEMENT
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Joslin Diabetes Center designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
To Obtain CME Credits
• Read the learning objectives and faculty disclosures.
• Participate in the activity.
• Complete the post-test and activity evaluation.
• Physicians who successfully complete the post-test and evaluation will receive CME credit.
• You must score with a 60% or higher on the post-test to receive credit for this activity.
• All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
Release Date: January 5, 2010
Expiration Date: January 4, 2011
ACKNOWLEDGEMENT
This activity is sponsored by Joslin Diabetes Center.
This activity is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.
If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.
Copyright © 2010 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.
Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center
Boston, MA
Julie Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA
James Neighbours, MEd
Assistant Director, Education Technology Services
Professional Education
Joslin Diabetes Center
Boston, MA
DISCLOSURE POLICY STATEMENT
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of the Joslin Diabetes Center.
Dr. Snow has no relevant financial relationships.
Dr. Levy has received grant/research support from, is on the speakers bureau and a consultant for Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Pfizer Inc. He is on the speaker's bureau and a consultant for Bristol-Myers Squibb Company, Daiichi Sankyo Inc., GlaxoSmithKline, Merck & Co. Inc., and Takeda Pharmaceuticals North America, Inc. He is a consultant for Boehringer Ingelheim Pharmaceuticals, Inc. Dr. Levy has received grant/research support from Novartis Pharmaceuticals Corporation and Novo Nordisk Inc.
Dr. Rolla is on the speakers bureau for Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk Inc., and F. Hoffman-La Roche Ltd.
Dr. Beaser is on the academic advisory board for AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company.
Ms. Brown has no relevant financial relationships.
Mr. Neighbours has no relevant financial relationships.
ACCREDITATION STATEMENT
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Joslin Diabetes Center designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
To Obtain CME Credits
• Read the learning objectives and faculty disclosures.
• Participate in the activity.
• Complete the post-test and activity evaluation.
• Physicians who successfully complete the post-test and evaluation will receive CME credit.
• You must score with a 60% or higher on the post-test to receive credit for this activity.
• All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
| PC Internet Explorer (v6 or greater), or Firefox |
MAC Safari |
Release Date: January 5, 2010
Expiration Date: January 4, 2011
ACKNOWLEDGEMENT
This activity is sponsored by Joslin Diabetes Center.
This activity is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.
If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.
Copyright © 2010 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.
